Genworth Financial Announces Fourth Quarter 2023 Results
- Genworth Financial, Inc. executed $35M in share repurchases in Q4 2023, totaling $384M through February 13, 2024, at an average price of $5.33 per share.
- Significant progress was made on the Long-Term Care Insurance (LTC) multi-year rate action plan (MYRAP), reducing the estimated remaining amount by $1.5B to approximately $5B.
- $127M of gross incremental premium was approved in the fourth quarter under the MYRAP, with $28B net present value achieved from in-force rate actions (IFAs) since 2012.
- The company reported a net loss of $212M, or $0.47 per diluted share, and an adjusted operating loss of $230M, or $0.51 per diluted share.
- Enact delivered strong performance, generating $552M in adjusted operating income and $245M in cash flows to Genworth for the full year.
- Enact's adjusted operating income was $129M with a 10% loss ratio. The estimated PMIERs sufficiency ratio was 161%.
- Life Insurance results included an unfavorable $179M after-tax impact from annual assumption updates, primarily due to persistency assumptions and mortality assumptions.
- Statutory pre-tax income was $148M, with a 303% RBC ratio, driven by LTC premium increases and benefit reductions, as well as favorable assumption updates in life insurance.
- The holding company cash and liquid assets stood at $350M at year-end, remaining above the company's cash target of two-times annual debt service.
- None.
Insights
The reported net loss of $212M and adjusted operating loss of $230M for Genworth Financial, Inc. in Q4 2023 reflect significant challenges in their Long-Term Care Insurance (LTC) and Life and Annuities segments. The LTC segment's unfavorable impacts from assumption updates and actual experience versus best estimate liability assumptions suggest a need for further rate increases or cost management strategies. The life insurance results were similarly affected by unfavorable assumption updates. These factors could signal potential volatility in the company's future earnings and may influence investor sentiment negatively.
However, the share repurchase program, with $35M executed in Q4 and $384M in total, at an average price of $5.33 per share, indicates management's confidence in the intrinsic value of the company. Share repurchases can be accretive to earnings per share and may provide support to the stock price in the short term. Still, investors must weigh this against the company's overall financial health and the sustainability of such capital return programs.
The progress on Genworth's Long-Term Care Insurance multi-year rate action plan (MYRAP), with a reduction of the estimated remaining amount left to achieve by $1.5B to approximately $5B, is a strategic move to stabilize the segment. The gross incremental premium of $127M approved in Q4 within the MYRAP and $28B net present value achieved since 2012 from in-force rate actions (IFAs), reflect proactive management of the legacy LTC business. These actions are critical in an industry where insurers have been grappling with the challenges of pricing LTC insurance products due to longer life expectancies and rising healthcare costs.
The statutory pre-tax income of $148M and RBC ratio of 303% for U.S. life insurance companies are within regulatory norms, suggesting adequate capitalization and solvency. However, the LTC segment's performance, with a reported adjusted operating loss of $151M, highlights ongoing pressures in this line of business. The industry-wide issue of managing long-term care risk continues to be a focal point for insurers, with implications for future profitability and risk management.
Genworth Financial's strategic emphasis on improving the financial condition of its LTC business and returning capital to shareholders through share repurchases and dividends from its Enact subsidiary is notable. The strong performance of Enact, with $552M in adjusted operating income for the full year, provides a diversified income stream that partially offsets the losses in the LTC and Life and Annuities segments. This diversification is a positive indicator for the company's resilience in the face of sector-specific headwinds.
Moreover, the primary insurance in-force increase and favorable pre-tax reserve release from Enact's mortgage insurance operations suggest a robust position in the private mortgage insurance market, despite a decrease in primary new insurance written due to elevated mortgage rates. Investors may view this as a sign of operational strength in a core business line, which could help cushion the impact of the LTC segment's performance on the overall business.
Strategic Highlights
-
Executed
in share repurchases in the quarter;$35M in total executed through February 13, 2024, at an average price of$384M per share with approximately 443M shares outstanding$5.33 -
Significant progress on Long-Term Care Insurance (LTC) multi-year rate action plan (MYRAP), reducing the estimated remaining amount left to achieve by
to approximately$1.5B $5B -
Achieved
of gross incremental premium approved in fourth quarter in the MYRAP,$127M net present value achieved from in-force rate actions (IFAs) since 2012$28B
Financial Highlights
-
Net loss1 of
, or$212M per diluted share, and adjusted operating loss1,2 of$0.47 , or$230M per diluted share$0.51 -
Received
in capital returns from Enact$128M -
Completed annual assumption updates with unfavorable impacts in life insurance and LTC of
, or$227M per diluted share$0.50 -
U.S. life insurance companies’ statutory pre-tax income3 of 4 and RBC5 ratio of$148M 303% 4 -
Genworth holding company cash and liquid assets of
at year-end$350M
“I’m proud of Genworth’s progress against our strategic priorities in 2023,” said Tom McInerney, President & CEO. “We successfully improved the financial condition of our legacy LTC business through our multi-year rate action plan, launched the innovative CareScout Quality Network, and returned
Consolidated GAAP Financial Highlights |
|||||||||||
Consolidated Metrics |
|
|
Q4 2023 |
|
Q3 2023 |
|
Q4 2022 |
|
|||
(Amounts in millions, except per share data) |
|
|
|
|
|
||||||
Net income (loss)1 |
|
|
$ |
(212) |
|
$ |
29 |
|
$ |
381 |
|
Earnings (loss) per diluted share1 |
|
|
$ |
(0.47) |
|
$ |
0.06 |
|
$ |
0.76 |
|
Adjusted operating income (loss)1,2 |
|
|
$ |
(230) |
|
$ |
42 |
|
$ |
338 |
|
Adjusted operating income (loss) per diluted share1,2 |
|
|
$ |
(0.51) |
|
$ |
0.09 |
|
$ |
0.67 |
|
Weighted-average diluted shares6 |
|
|
|
449.4 |
|
|
466.0 |
|
|
502.9 |
|
- Net loss and adjusted operating loss reflect losses in LTC and Life and Annuities, which include annual assumption updates, partially offset by Enact’s strong operating performance
-
Net investment gains, net of taxes, increased net income by
in the current quarter, compared with net investment losses that decreased net income by$30 million in the prior year. The investment gains in the current quarter were driven primarily by mark-to-market adjustments on limited partnership and equity securities, as well as derivatives gains, partially offset by net trading losses$4 million -
Net investment income was
in the quarter, up from$810 million in the prior year as higher income from limited partnerships and investment yields were partially offset by lower average invested assets$787 million
Enact |
|||||||||||
GAAP Operating Metrics |
|
|
Q4 2023 |
|
Q3 2023 |
|
Q4 2022 |
|
|||
(Dollar amounts in millions) |
|
|
|
|
|
||||||
Adjusted operating income7 |
|
|
$ |
129 |
|
$ |
134 |
|
$ |
120 |
|
Primary new insurance written |
|
|
$ |
10,453 |
|
$ |
14,391 |
|
$ |
15,145 |
|
Loss ratio |
|
|
|
|
|
|
|
|
|
|
|
Equity8 |
|
|
$ |
3,785 |
|
$ |
3,646 |
|
$ |
3,356 |
|
-
Current quarter results reflect a favorable pre-tax reserve release of
, primarily from cure performance on delinquencies from 2022 and earlier, including delinquencies related to the coronavirus pandemic (COVID). The prior quarter and prior year included favorable net pre-tax reserve releases of$53 million and$55 million , respectively$42 million -
Net investment income was
in the current quarter, up from$57 million in the prior year from higher yields and higher average invested assets$45 million -
Primary insurance in-force increased six percent versus the prior year to
, driven by new insurance written (NIW) and continued elevated persistency$263 billion - Primary NIW was down 31 percent versus the prior year and 27 percent versus the prior quarter primarily due to a smaller estimated private mortgage insurance market as both refinancing and purchase originations were impacted by elevated mortgage rates
- New delinquencies increased 14 percent to 11,706 from 10,304 in the prior year, primarily from the aging of large, new books
Capital Metric |
|
|
Q4 2023 |
|
Q3 2023 |
|
Q4 2022 |
|
||||||
|
|
|
|
|
|
|||||||||
PMIERs Sufficiency Ratio4,9 |
|
|
|
161 |
% |
|
|
162 |
% |
|
|
165 |
% |
|
-
Enact paid a quarterly dividend of
per share and a special dividend of$0.16 per share in the current quarter$0.71 -
Estimated PMIERs sufficiency ratio was 161 percent,
above requirements$1,887 million
Long-Term Care Insurance |
|||||||||||
GAAP Operating Metrics |
|
|
Q4 2023 |
Q3 2023 |
Q4 2022 |
||||||
(Amounts in millions) |
|
|
|||||||||
Adjusted operating income (loss) |
|
|
$ |
(151) |
|
$ |
(71) |
|
$ |
204 |
|
Premiums |
|
|
$ |
615 |
|
$ |
621 |
|
$ |
639 |
|
Net investment income |
|
|
$ |
489 |
|
$ |
482 |
|
$ |
470 |
|
Liability remeasurement gains (losses) |
|
|
$ |
(188) |
|
$ |
(104) |
|
$ |
255 |
|
Cash flow assumption updates |
|
|
|
(61) |
|
|
6 |
|
|
303 |
|
Actual to expected experience |
|
|
|
(127) |
|
|
(110) |
|
|
(48) |
|
-
Premiums related to IFAs of
pre-tax, up$255 million versus the prior year$10 million - Net investment income up versus the prior quarter and prior year, driven primarily by higher limited partnership income
-
Liability remeasurement loss of
pre-tax; unfavorable after-tax impact of$188 million $149 million -
Unfavorable impact of
pre-tax from assumption updates, primarily related to updates to healthy life assumptions to better reflect near-term experience, partially offset by a favorable update to disabled life mortality assumptions for expected short-term trends. Updates also included assumptions for future IFA approvals and benefit reductions based on recent favorable experience and reflection of the Choice II legal settlement, which had a muted income statement impact in the current quarter because it primarily impacted profitable uncapped cohorts$61 million -
Unfavorable actual experience versus best estimate liability assumptions of
pre-tax, or$127 million after-tax per diluted share, primarily on unprofitable capped cohorts driven by higher claims and unfavorable legal settlement timing impacts$0.22
-
Unfavorable impact of
-
Liability remeasurement gain of
pre-tax in the prior year included favorable assumption updates of$255 million pre-tax, largely related to the PCS I and II legal settlement, which primarily impacted capped cohorts$303 million
Life and Annuities |
|||||||||||
GAAP Adjusted Operating Income (Loss) |
|
|
Q4 2023 |
|
Q3 2023 |
|
Q4 2022 |
|
|||
(Amounts in millions) |
|
|
|
|
|
||||||
Life Insurance |
|
|
$ |
(206) |
|
$ |
(25) |
|
$ |
1 |
|
Fixed Annuities |
|
|
|
9 |
|
|
17 |
|
|
14 |
|
Variable Annuities |
|
|
|
14 |
|
|
5 |
|
|
8 |
|
Total Life and Annuities |
|
|
$ |
(183) |
|
$ |
(3) |
|
$ |
23 |
|
Life Insurance
-
Life insurance results included an unfavorable
after-tax impact for the annual assumption updates in the current quarter, primarily from persistency assumptions related to certain universal life (UL) products with secondary guarantees and mortality assumptions for term UL, UL and term products, including more modest mortality improvement and expected short-term trends post-COVID$179 million - Mortality experience was unfavorable in the current quarter compared to the prior quarter and prior year
- Deferred acquisition costs amortization expense was lower than prior year, primarily driven by lower lapses and block runoff
Annuities
- Fixed annuities results included less favorable fixed payout annuity mortality compared to the prior quarter and lower net spreads primarily related to block runoff compared to the prior year
- Variable annuities reported higher adjusted operating income from favorable assumption updates, as well as favorable mortality compared to the prior quarter
(Dollar amounts in millions) |
|
|
Q4 2023 |
|
Q3 2023 |
|
Q4 2022 |
|
||||||
|
|
|
|
|
|
|||||||||
Statutory Pre-Tax Income (Loss)4 |
|
|
$ |
|
148 |
|
$ |
|
30 |
|
$ |
|
230 |
|
Long-Term Care Insurance |
|
|
|
|
(9) |
|
|
|
21 |
|
|
|
(58) |
|
Life Insurance |
|
|
|
|
82 |
|
|
|
(40) |
|
|
|
144 |
|
Fixed Annuities |
|
|
|
|
16 |
|
|
|
32 |
|
|
|
31 |
|
Variable Annuities |
|
|
|
|
59 |
|
|
|
17 |
|
|
|
113 |
|
GLIC Consolidated RBC Ratio4 |
|
|
|
303 |
% |
|
|
291 |
% |
|
|
291 |
% |
|
-
Statutory pre-tax income was
in the current quarter, driven by:$148 million - LTC continues to benefit from premium increases and benefit reductions from IFAs, including more favorable impacts from reserve releases related to legal settlements compared to the prior quarter, but this benefit was more than offset by higher claims as the block ages
-
LTC results also included a
increase in cash flow testing reserves in GLICNY, partially offset by a net$87 million pre-tax benefit from assumption updates$29 million -
Life insurance results included a
pre-tax favorable impact from assumption updates, primarily related to certain UL products with secondary guarantees, as a favorable change in the prescribed reinvestment rate more than offset the unfavorable assumption updates for persistency and mortality$99 million - Fixed annuities reflect less favorable mortality as well as lower net spread income from block runoff
- Variable annuity reserves include net benefit as equity market and interest rate movements were more favorable than the prior quarter
- Current quarter GLIC consolidated RBC ratio was 303 percent, up from the prior year driven primarily by earnings in annuities, including a net benefit to variable annuities from the impact of equity market and interest rate performance in the year, and the net favorable impact of assumption updates, primarily in life insurance
-
Cash flow testing margin in GLIC for 2023 was within the
range after the completion of assumption updates$0.5 -$1.0 billion
Corporate and Other
-
The current quarter adjusted operating loss was
, up from$25 million in the prior quarter and$18 million in the prior year, primarily from taxes and expenses related to new growth initiatives with CareScout$9 million
Holding Company Cash and Liquid Assets |
|||||||||||
(Amounts in millions) |
|
|
Q4 2023 |
|
Q3 2023 |
|
Q4 2022 |
|
|||
|
|
|
|
|
|
||||||
Holding Company Cash and Liquid Assets11,12 |
|
|
$ |
350 |
|
$ |
232 |
|
$ |
307 |
|
-
Cash and liquid assets of
remained above the company’s cash target of two-times annual debt service$350 million -
Cash inflows during the current quarter consisted of
from intercompany tax payments and$64 million from Enact capital returns, which included a$128 million quarterly dividend, a$21 million special dividend and$92 million in share repurchase proceeds$15 million -
Current quarter cash outflows included
in share repurchases,$35 million related to debt servicing costs and the repurchase of$21 million principal of the company’s 2034 and 2066 debt$21 million
Returns to Shareholders
-
In the fourth quarter of 2023, the company repurchased
of its common stock at an average price of$35 million per share$5.90 -
Subsequently, the company repurchased an additional
of its common stock at an average price of$25 million per share, approximately 443 million shares were outstanding as of February 13, 2024$6.13
About Genworth Financial
Genworth Financial, Inc. (NYSE: GNW) is a Fortune 500 company focused on empowering families to navigate the aging journey with confidence, now and in the future. Headquartered in
Conference Call Information
Investors are encouraged to read this press release, summary presentation and financial supplement which are now posted on the company’s website, http://investor.genworth.com.
Genworth will conduct a conference call on February 22, 2024 at 9:00 a.m. (ET) to discuss its fourth quarter results, which will be accessible via:
-
Telephone: 888-208-1820 or 323-794-2110 (outside the
U.S. ); conference ID # 6245584; or - Webcast: https://investor.genworth.com/news-events/ir-calendar
Allow at least 15 minutes prior to the call time to register for the call. A replay of the webcast will be available on the company’s website for one year.
Use of Non-GAAP Measures
Management uses non-GAAP financial measures entitled "adjusted operating income (loss)" and "adjusted operating income (loss) per share” to evaluate performance and allocate resources. Adjusted operating income (loss) per share is derived from adjusted operating income (loss). The company defines adjusted operating income (loss) as income (loss) from continuing operations excluding the after-tax effects of income (loss) from continuing operations attributable to noncontrolling interests, net investment gains (losses), changes in fair value of market risk benefits and associated hedges, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, restructuring costs and infrequent or unusual non-operating items. A component of the company’s net investment gains (losses) is the result of estimated future credit losses, the size and timing of which can vary significantly depending on market credit cycles. In addition, the size and timing of other investment gains (losses) can be subject to the company’s discretion and are influenced by market opportunities, as well as asset-liability matching considerations. The company excludes net investment gains (losses), changes in fair value of market risk benefits and associated hedges, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, restructuring costs and infrequent or unusual non-operating items from adjusted operating income (loss) because, in the company’s opinion, they are not indicative of overall operating performance.
While some of these items may be significant components of net income (loss) in accordance with GAAP, the company believes that adjusted operating income (loss), and measures that are derived from or incorporate adjusted operating income (loss), including adjusted operating income (loss) per share on a basic and diluted basis, are appropriate measures that are useful to investors because they identify the income (loss) attributable to the ongoing operations of the business. Management also uses adjusted operating income (loss), among other key performance indicators, as a basis for determining awards and compensation for senior management and to evaluate performance on a basis comparable to that used by analysts. However, the items excluded from adjusted operating income (loss) have occurred in the past and could, and in some cases will, recur in the future. Adjusted operating income (loss) and adjusted operating income (loss) per share on a basic and diluted basis are not substitutes for net income (loss) or net income (loss) per share on a basic and diluted basis determined in accordance with GAAP. In addition, the company’s definition of adjusted operating income (loss) may differ from the definitions used by other companies.
Adjustments to reconcile net income (loss) to adjusted operating income (loss) assume a 21 percent tax rate and are net of the portion attributable to noncontrolling interests. Changes in fair value of market risk benefits and associated hedges are adjusted to exclude changes in reserves, attributed fees and benefit payments.
The tables at the end of this press release provide a reconciliation of net income (loss) available to Genworth Financial, Inc.'s common stockholders to adjusted operating income (loss) for the three and twelve months ended December 31, 2023 and 2022, as well as the three months ended September 30, 2023 and reflect adjusted operating income (loss) as determined in accordance with accounting guidance related to segment reporting.
Long-duration targeted improvements
On January 1, 2023, the company adopted new GAAP accounting guidance that significantly changed the recognition and measurement of long-duration insurance contracts, commonly known as LDTI. This accounting guidance impacted the company’s LTC, life insurance and annuity products and was applied as of January 1, 2021. While the new guidance has had a significant impact on existing GAAP financial statements and disclosures, it does not impact the cash flows or underlying economics of the business, business strategy, statutory net income (loss) or RBC of the
All financial information in this press release is based on the company's implementation of LDTI and is currently unaudited. It is possible that the final audited financial results may differ, perhaps materially, from the information included in this press release.
Statutory Accounting Data
The company presents certain supplemental statutory data for GLIC and its consolidating life insurance subsidiaries that has been prepared on the basis of statutory accounting principles (SAP). GLIC and its consolidating life insurance subsidiaries file financial statements with state insurance regulatory authorities and the National Association of Insurance Commissioners that are prepared using SAP, an accounting basis either prescribed or permitted by such authorities. Due to differences in methodology between SAP and GAAP, the values for assets, liabilities and equity, and the recognition of income and expenses, reflected in financial statements prepared in accordance with GAAP are materially different from those reflected in financial statements prepared under SAP. This supplemental statutory data should not be viewed as an alternative to, or used in lieu of, GAAP.
This supplemental statutory data includes the company action level RBC ratio for GLIC and its consolidating life insurance subsidiaries as well as combined statutory pre-tax earnings from the principal
Cautionary Note Regarding Forward-Looking Statements
This press release contains certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by words such as “expects,” “intends,” “anticipates,” “plans,” “believes,” “seeks,” “estimates,” “will” or words of similar meaning and include, but are not limited to, statements regarding the outlook for the company’s future business and financial performance. Examples of forward-looking statements include statements the company makes relating to potential dividends or share repurchases; future return of capital by Enact Holdings, Inc. (Enact Holdings), including share repurchases, and quarterly and special dividends; the cumulative amount of rate action benefits required for the company’s long-term care insurance business; future financial performance, including the expectation that adverse quarterly variation from actual to expected variances in the company’s long-term care insurance business could persist resulting in future remeasurement losses; future financial condition of the company’s businesses; liquidity and new lines of business or new products and services, such as those the company is pursuing with our CareScout business (CareScout); as well as statements the company makes regarding the potential occurrence of a recession.
Forward-looking statements are based on management’s current expectations and assumptions, which are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Actual outcomes and results may differ materially from those in the forward-looking statements due to global political, economic, inflation, business, competitive, market, regulatory and other factors and risks, including but not limited to, the following:
- the inability to successfully launch new lines of business or new products and services, such as those the company is pursuing with CareScout;
- the company’s failure to maintain self-sustainability of its long-term care insurance business, including as a result of the inability to achieve desired levels of in-force rate actions and/or the timing of its future premium rate increases and associated benefit reductions taking longer to achieve than originally assumed; other regulatory actions negatively impacting the company’s life insurance businesses and/or the inability to establish new long-term care insurance business;
- inaccuracies or changes in estimates, assumptions, methodologies, valuations, projections and/or models, which result in inadequate reserves or other adverse results (including as a result of any changes in connection with quarterly, annual or other reviews);
- the impact on holding company liquidity caused by an inability to receive dividends or any other returns of capital from Enact Holdings, and limited sources of capital and financing;
-
adverse changes to the structure, or requirements of Federal National Mortgage Association (Fannie Mae), Federal Home Loan Mortgage Corporation (Freddie Mac) or the
U.S. mortgage insurance market; an increase in the number of loans insured through federal government mortgage insurance programs, including those offered by the Federal Housing Administration; the inability of Enact Holdings and/or itsU.S. mortgage insurance subsidiaries to continue to meet the requirements mandated by PMIERs (or any adverse changes thereto), inability to meet minimum statutory capital requirements of applicable regulators or the mortgage insurer eligibility requirements of Fannie Mae or Freddie Mac; -
changes in economic, market and political conditions including as a result of high inflation, labor shortages, displacements related to COVID and elevated interest rates, including actions taken by the
U.S. Federal Reserve to increase interest rates to combat inflation and slow economic growth, which could heighten the risk of a future recession; unanticipated financial events, which could lead to market-wide liquidity problems and other significant market disruption resulting in losses, defaults or credit rating downgrades of other financial institutions; deterioration in economic conditions, a recession or a decline in home prices, all of which could be driven by many potential factors, including political and economic instability or changes in government policies, and fluctuations in international securities markets; - rating downgrades or potential downgrades in liquidity, financial strength and credit ratings; counterparty credit risks; defaults by counterparties to reinsurance arrangements or derivative instruments; defaults or other events impacting the value of invested assets;
- changes in tax rates or tax laws, or changes in accounting and reporting standards;
- litigation and regulatory investigations or other actions, including commercial and contractual disputes with counterparties;
- the inability to retain, attract and motivate qualified employees or senior management;
-
the occurrence of natural or man-made disasters, including geopolitical tensions and war (including the Russian invasion of
Ukraine and the Israel-Hamas conflict), a public health emergency, including pandemics, or climate change; - the inability to effectively manage information technology systems, cyber incidents or other failures, disruptions or security breaches of the company or its third-party vendors such as the MOVEit cybersecurity incident; and
-
other factors described in the risk factors contained in Item 1A of the company’s Annual Report on Form 10-K filed with the
U.S. Securities and Exchange Commission on February 28, 2023.
The company provides additional information regarding these risks and uncertainties in its Annual Report on Form 10-K. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Accordingly, for the foregoing reasons, the company cautions you against relying on any forward-looking statements. The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required under applicable securities laws.
Condensed Consolidated Statements of Income |
||||||||||||||||||||
(Amounts in millions, except per share amounts) |
||||||||||||||||||||
(Unaudited) |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Three months ended |
|
Twelve months ended |
|
Three months ended |
||||||||||||||
|
|
December 31, |
|
December 31, |
|
September 30, |
||||||||||||||
|
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
2023 |
||||||||||
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Premiums |
|
$ |
904 |
|
|
$ |
918 |
|
|
$ |
3,636 |
|
|
$ |
3,680 |
|
|
$ |
915 |
|
Net investment income |
|
|
810 |
|
|
|
787 |
|
|
|
3,183 |
|
|
|
3,146 |
|
|
|
801 |
|
Net investment gains (losses) |
|
|
38 |
|
|
|
(5 |
) |
|
|
23 |
|
|
|
(2 |
) |
|
|
(43 |
) |
Policy fees and other income |
|
|
159 |
|
|
|
167 |
|
|
|
646 |
|
|
|
671 |
|
|
|
158 |
|
Total revenues |
|
|
1,911 |
|
|
|
1,867 |
|
|
|
7,488 |
|
|
|
7,495 |
|
|
|
1,831 |
|
Benefits and expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Benefits and other changes in policy reserves |
|
|
1,233 |
|
|
|
1,209 |
|
|
|
4,783 |
|
|
|
4,303 |
|
|
|
1,199 |
|
Liability remeasurement (gains) losses |
|
|
416 |
|
|
|
(267 |
) |
|
|
587 |
|
|
|
(290 |
) |
|
|
116 |
|
Changes in fair value of market risk benefits and associated hedges |
|
|
14 |
|
|
|
(56 |
) |
|
|
(12 |
) |
|
|
(104 |
) |
|
|
(24 |
) |
Interest credited |
|
|
124 |
|
|
|
125 |
|
|
|
503 |
|
|
|
504 |
|
|
|
127 |
|
Acquisition and operating expenses, net of deferrals |
|
|
248 |
|
|
|
225 |
|
|
|
942 |
|
|
|
1,285 |
|
|
|
228 |
|
Amortization of deferred acquisition costs and intangibles |
|
|
63 |
|
|
|
74 |
|
|
|
264 |
|
|
|
326 |
|
|
|
65 |
|
Interest expense |
|
|
30 |
|
|
|
28 |
|
|
|
118 |
|
|
|
106 |
|
|
|
30 |
|
Total benefits and expenses |
|
|
2,128 |
|
|
|
1,338 |
|
|
|
7,185 |
|
|
|
6,130 |
|
|
|
1,741 |
|
Income (loss) from continuing operations before income taxes |
|
|
(217 |
) |
|
|
529 |
|
|
|
303 |
|
|
|
1,365 |
|
|
|
90 |
|
Provision (benefit) for income taxes |
|
|
(36 |
) |
|
|
119 |
|
|
|
104 |
|
|
|
319 |
|
|
|
30 |
|
Income (loss) from continuing operations |
|
|
(181 |
) |
|
|
410 |
|
|
|
199 |
|
|
|
1,046 |
|
|
|
60 |
|
Loss from discontinued operations, net of taxes |
|
|
(2 |
) |
|
|
(2 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Net income (loss) |
|
|
(183 |
) |
|
|
408 |
|
|
|
199 |
|
|
|
1,046 |
|
|
|
60 |
|
Less: net income from continuing operations attributable to noncontrolling interests |
|
|
29 |
|
|
|
27 |
|
|
|
123 |
|
|
|
130 |
|
|
|
31 |
|
Less: net income from discontinued operations attributable to noncontrolling interests |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Net income (loss) available to Genworth Financial, Inc.'s common stockholders |
|
$ |
(212 |
) |
|
$ |
381 |
|
|
$ |
76 |
|
|
$ |
916 |
|
|
$ |
29 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Net income (loss) available to Genworth Financial, Inc.'s common stockholders: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders |
|
$ |
(210 |
) |
|
$ |
383 |
|
|
$ |
76 |
|
|
$ |
916 |
|
|
$ |
29 |
|
Loss from discontinued operations available to Genworth Financial, Inc.'s common stockholders |
|
|
(2 |
) |
|
|
(2 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Net income (loss) available to Genworth Financial, Inc.'s common stockholders |
|
$ |
(212 |
) |
|
$ |
381 |
|
|
$ |
76 |
|
|
$ |
916 |
|
|
$ |
29 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Basic |
|
$ |
(0.47 |
) |
|
$ |
0.77 |
|
|
$ |
0.16 |
|
|
$ |
1.82 |
|
|
$ |
0.06 |
|
Diluted |
|
$ |
(0.47 |
) |
|
$ |
0.76 |
|
|
$ |
0.16 |
|
|
$ |
1.79 |
|
|
$ |
0.06 |
|
Net income (loss) available to Genworth Financial, Inc.'s common stockholders per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Basic |
|
$ |
(0.47 |
) |
|
$ |
0.77 |
|
|
$ |
0.16 |
|
|
$ |
1.82 |
|
|
$ |
0.06 |
|
Diluted |
|
$ |
(0.47 |
) |
|
$ |
0.76 |
|
|
$ |
0.16 |
|
|
$ |
1.79 |
|
|
$ |
0.06 |
|
Weighted-average common shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Basic |
|
|
449.4 |
|
|
|
496.5 |
|
|
|
468.8 |
|
|
|
504.4 |
|
|
|
460.5 |
|
Diluted6 |
|
|
449.4 |
|
|
|
502.9 |
|
|
|
474.9 |
|
|
|
510.9 |
|
|
|
466.0 |
|
Reconciliation of Net Income (Loss) to Adjusted Operating Income (Loss) |
||||||||||||||||||||
(Amounts in millions, except per share amounts) |
||||||||||||||||||||
(Unaudited) |
||||||||||||||||||||
|
|
|
|
|
|
|
||||||||||||||
|
|
Three |
|
Twelve |
|
Three |
||||||||||||||
|
|
months ended |
|
months ended |
|
months ended |
||||||||||||||
|
|
December 31, |
|
December 31, |
|
September 30, |
||||||||||||||
|
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
2023 |
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Net income (loss) available to Genworth Financial, Inc.'s common stockholders |
|
$ |
(212 |
) |
|
$ |
381 |
|
|
$ |
76 |
|
|
$ |
916 |
|
|
$ |
29 |
|
Add: net income from continuing operations attributable to noncontrolling interests |
|
|
29 |
|
|
|
27 |
|
|
|
123 |
|
|
|
130 |
|
|
|
31 |
|
Add: net income from discontinued operations attributable to noncontrolling interests |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Net income (loss) |
|
|
(183 |
) |
|
|
408 |
|
|
|
199 |
|
|
|
1,046 |
|
|
|
60 |
|
Less: loss from discontinued operations, net of taxes |
|
|
(2 |
) |
|
|
(2 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Income (loss) from continuing operations |
|
|
(181 |
) |
|
|
410 |
|
|
|
199 |
|
|
|
1,046 |
|
|
|
60 |
|
Less: net income from continuing operations attributable to noncontrolling interests |
|
|
29 |
|
|
|
27 |
|
|
|
123 |
|
|
|
130 |
|
|
|
31 |
|
Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders |
|
|
(210 |
) |
|
|
383 |
|
|
|
76 |
|
|
|
916 |
|
|
|
29 |
|
Adjustments to income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Net investment (gains) losses, net13 |
|
|
(38 |
) |
|
|
5 |
|
|
|
(25 |
) |
|
|
2 |
|
|
|
43 |
|
Changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges14 |
|
|
13 |
|
|
|
(64 |
) |
|
|
(22 |
) |
|
|
(142 |
) |
|
|
(26 |
) |
(Gains) losses on early extinguishment of debt |
|
|
(1 |
) |
|
|
(1 |
) |
|
|
(2 |
) |
|
|
6 |
|
|
|
— |
|
Expenses related to restructuring |
|
|
— |
|
|
|
1 |
|
|
|
4 |
|
|
|
2 |
|
|
|
— |
|
Pension plan termination costs |
|
|
— |
|
|
|
2 |
|
|
|
— |
|
|
|
8 |
|
|
|
— |
|
Taxes on adjustments |
|
|
6 |
|
|
|
12 |
|
|
|
10 |
|
|
|
26 |
|
|
|
(4 |
) |
Adjusted operating income (loss) |
|
$ |
(230 |
) |
|
$ |
338 |
|
|
$ |
41 |
|
|
$ |
818 |
|
|
$ |
42 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Adjusted operating income (loss): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Enact segment |
|
$ |
129 |
|
|
$ |
120 |
|
|
$ |
552 |
|
|
$ |
578 |
|
|
$ |
134 |
|
Long-Term Care Insurance segment |
|
|
(151 |
) |
|
|
204 |
|
|
|
(242 |
) |
|
|
320 |
|
|
|
(71 |
) |
Life and Annuities segment: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Life Insurance |
|
|
(206 |
) |
|
|
1 |
|
|
|
(275 |
) |
|
|
(111 |
) |
|
|
(25 |
) |
Fixed Annuities |
|
|
9 |
|
|
|
14 |
|
|
|
50 |
|
|
|
62 |
|
|
|
17 |
|
Variable Annuities |
|
|
14 |
|
|
|
8 |
|
|
|
37 |
|
|
|
21 |
|
|
|
5 |
|
Total Life and Annuities segment |
|
|
(183 |
) |
|
|
23 |
|
|
|
(188 |
) |
|
|
(28 |
) |
|
|
(3 |
) |
Corporate and Other |
|
|
(25 |
) |
|
|
(9 |
) |
|
|
(81 |
) |
|
|
(52 |
) |
|
|
(18 |
) |
Adjusted operating income (loss) |
|
$ |
(230 |
) |
|
$ |
338 |
|
|
$ |
41 |
|
|
$ |
818 |
|
|
$ |
42 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Net income (loss) available to Genworth Financial, Inc.'s common stockholders per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Basic |
|
$ |
(0.47 |
) |
|
$ |
0.77 |
|
|
$ |
0.16 |
|
|
$ |
1.82 |
|
|
$ |
0.06 |
|
Diluted |
|
$ |
(0.47 |
) |
|
$ |
0.76 |
|
|
$ |
0.16 |
|
|
$ |
1.79 |
|
|
$ |
0.06 |
|
Adjusted operating income (loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Basic |
|
$ |
(0.51 |
) |
|
$ |
0.68 |
|
|
$ |
0.09 |
|
|
$ |
1.62 |
|
|
$ |
0.09 |
|
Diluted |
|
$ |
(0.51 |
) |
|
$ |
0.67 |
|
|
$ |
0.09 |
|
|
$ |
1.60 |
|
|
$ |
0.09 |
|
Weighted-average common shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Basic |
|
|
449.4 |
|
|
|
496.5 |
|
|
|
468.8 |
|
|
|
504.4 |
|
|
|
460.5 |
|
Diluted6 |
|
|
449.4 |
|
|
|
502.9 |
|
|
|
474.9 |
|
|
|
510.9 |
|
|
|
466.0 |
_________________________________________ | |
1 |
All references reflect amounts available to Genworth’s common stockholders. |
2 |
This is a financial measure that is not calculated based on |
3 |
Net gain from operations before dividends to policyholders, refunds to members and federal income taxes for Genworth Life Insurance Company (GLIC), Genworth Life and Annuity Insurance Company (GLAIC) and Genworth Life Insurance Company of |
4 |
Company estimate for the fourth quarter of 2023 due to timing of the preparation of the filing(s). |
5 |
Risk-based capital ratio based on company action level for GLIC consolidated. |
6 |
Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of the company’s loss from continuing operations available to Genworth Financial, Inc.’s common stockholders for the three months ended December 31, 2023, the company was required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share as the inclusion of shares for performance stock units, restricted stock units and other equity-based awards of 6.3 million would have been antidilutive to the calculation. If the company had not incurred a loss from continuing operations available to Genworth Financial, Inc.’s common stockholders for the three months ended December 31, 2023, dilutive potential weighted-average common shares outstanding would have been 455.7 million. |
7 |
Reflects Genworth’s ownership excluding noncontrolling interests of |
8 |
Reflects Genworth’s ownership of equity including accumulated other comprehensive income and excluding noncontrolling interests of |
9 |
The Private Mortgage Insurer Eligibility Requirements (PMIERs) sufficiency ratio is calculated as available assets divided by required assets as defined within PMIERs. |
10 |
Genworth’s principal |
11 |
Holding company cash and liquid assets comprises assets held in Genworth Holdings, Inc. (the issuer of outstanding public debt) which is a wholly-owned subsidiary of Genworth Financial, Inc. |
12 |
Genworth Holdings, Inc. held no short-term investments or |
13 |
Net investment (gains) losses were adjusted for the portion attributable to noncontrolling interests of |
14 |
Changes in fair value of market risk benefits and associated hedges were adjusted to exclude changes in reserves, attributed fees and benefit payments of |
View source version on businesswire.com: https://www.businesswire.com/news/home/20240220615637/en/
Investors:
Brian Johnson
InvestorInfo@genworth.com
Media:
Amy Rein
Amy.Rein@genworth.com
Source: Genworth Financial, Inc.
FAQ
What was the total amount executed in share repurchases by Genworth Financial, Inc. in Q4 2023?
How much was the estimated remaining amount reduced in the Long-Term Care Insurance (LTC) multi-year rate action plan (MYRAP) by Genworth Financial, Inc.?
What was the net loss reported by Genworth Financial, Inc. in Q4 2023?
How much adjusted operating income was generated by Enact for Genworth Financial, Inc. in the full year?
What was Enact's adjusted operating income in Q4 2023?
What was the statutory pre-tax income reported by Genworth Financial, Inc. in Q4 2023?
What was the holding company cash and liquid assets amount at year-end for Genworth Financial, Inc.?
What was the PMIERs sufficiency ratio reported by Genworth Financial, Inc. in Q4 2023?